A method for preparing recombinant coxsackievirus a16 virus-like particles
A coxsackie virus, virus-like technology, applied in the field of immunity, can solve the problems of lack of viral nucleic acid and non-infectivity, and achieve the effect of good immunogenicity, uniform shape and stable character
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0053] The preparation of embodiment 1 virus particle
[0054] 1. Selection of expressed genes and optimal design of codons
[0055] The DNA sequence encoding CA16-P1 protein and CA16-3C protein refers to the Chinese strain SZ / HK08-7 (GenBank: GQ279371.1), and the amino acid sequence of the CA16-P1 protein of the SZ / HK08-7 strain is shown in SEQ ID NO: 1, CA16 The amino acid sequence of -3C protein is shown in SEQ ID NO:2.
[0056] The wild-type DNA sequence encoding the CA16-P1 protein shown in SEQIDNO: 1 and the CA16-3C protein shown in SEQIDNO: 2 in the SZ / HK08-7 strain was modified, and the codons were used as frequently as possible in Hansenula. codons, while avoiding transcription factor binding regions, repetitive sequences, and RNA higher-order structures that may affect expression. After codon optimization, the sequence of the recombinant gene encoding the CA16-P1 protein is shown in SEQ ID NO:3, and the sequence of the recombinant gene encoding the CA16-3C protein ...
Embodiment 2
[0090] Antigen performance detection of embodiment 2 virus particle
[0091] 1. VLP Vaccine Preparation
[0092] The purified CA16 virus-like particle protein is adsorbed with aluminum adjuvant to prepare the immunogenic CA16 vaccine.
[0093] 2. Determination of the immunogenicity of CA16 virus-like particles
[0094] SPF grade BALB / c mice aged 6-8 weeks were selected and divided into 4 groups with 6 mice in each group. One group of mice was immunized with buffer (50mMPBpH7.0) containing aluminum adjuvant (as a negative control group), and the other three groups were immunized with 1 μg / mouse, 0.1 μg / mouse, and 0.01 μg / mouse, respectively. They were immunized by subcutaneous injection on the 0th and 14th day, and were immunized twice, and blood was collected two weeks after the second immunization. Place the collected blood at 4°C overnight, centrifuge at 5000g for 10 minutes, and absorb the supernatant to obtain the mouse polyantiserum, store it at -20°C, and detect the p...
PUM
| Property | Measurement | Unit |
|---|---|---|
| diameter | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
Login to View More 